论文部分内容阅读
近年来,随着对输血引起的各种不良反应的认识,临床上自体血的使用呈增长趋势。肿瘤手术病人输同种异体血是临床常用的方法。针对人们关注的输血后可因主要组织相容性抗原(HLA)的异体抗原作用,使受血者产生免疫抑制,导致免疫力下降,并使术后感染与肿瘤切除后复发率增加,因而使人们对输血产生了许多顾虑。我院自2000年12月～2003年12月在肿瘤手术病人中采取自身储血,术中回输的方法,取得了一定的效果,现报告如下。
In recent years, with the understanding of various adverse reactions caused by blood transfusion, the clinical use of autologous blood is increasing. Tumor surgery patients with allogeneic blood transfusion is a commonly used method. After the transfusion of interest, allogeneic antigens of major histocompatibility antigens (HLA) can be immunosuppressed in recipients, resulting in decreased immunity and increased postoperative infection and recurrence rate after tumor resection People have a lot of concerns about blood transfusions. Our hospital from December 2000 to December 2003 in the operation of cancer patients to take their own blood, transfusion during surgery, and achieved some results, are as follows.